These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 3183460

  • 21. [In vitro effects of X-irradiation on NK activity and its augmentation by OK-432 treatment].
    Nesumi N, Konishi J, Misaki T, Ono K, Abe M, Torizuka K.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 May 25; 45(5):752-63. PubMed ID: 4047930
    [No Abstract] [Full Text] [Related]

  • 22. Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model.
    Hernandez-Ilizaliturri FJ, Jupudy V, Ostberg J, Oflazoglu E, Huberman A, Repasky E, Czuczman MS.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):5866-73. PubMed ID: 14676108
    [Abstract] [Full Text] [Related]

  • 23. [Studies of immunotherapy of malignant urogenital tumors: 2nd report. Changes in the K-cell population of the peripheral blood in patients with malignant tumors and the significance of antibody dependent cell-mediated cytotoxicity (ADCC) in OK-432 immunotherapy].
    Fujioka T, Tanji S, Koike H, Suzuki K, Aoki H, Banya Y, Kubo T, Ohhori T.
    Nihon Hinyokika Gakkai Zasshi; 1987 Jan 01; 78(1):29-38. PubMed ID: 3599595
    [No Abstract] [Full Text] [Related]

  • 24. Monoclonal antibody to a human salivary gland adenocarcinoma cell line: augmentation of antibody-dependent cell-mediated cytotoxicity activity by streptococcal preparation OK-432 in human salivary gland adenocarcinoma-bearing nude mice given the antibody.
    Kaji R, Yoshida H, Yanagawa T, Sato M.
    J Biol Response Mod; 1989 Oct 01; 8(5):488-500. PubMed ID: 2552025
    [Abstract] [Full Text] [Related]

  • 25. [A basic study of combination cancer immunotherapy with OK-432 and rIL-2--induction of lymphokine-activated killer (LAK) precursor cells in murine spleen by intravenous administration of OK-432].
    Shimoda K, Saito T, Kobayashi M.
    Nihon Gan Chiryo Gakkai Shi; 1988 Jul 20; 23(7):1566-73. PubMed ID: 3263451
    [No Abstract] [Full Text] [Related]

  • 26. Activation of cytotoxic polymorphonuclear leukocytes by in vivo administration of a streptococcal preparation, OK-432.
    Watabe S, Sendo F, Kimura S, Arai S.
    J Natl Cancer Inst; 1984 Jun 20; 72(6):1365-70. PubMed ID: 6587156
    [Abstract] [Full Text] [Related]

  • 27. Effects of interleukin-2, OK-432 and interferon-gamma on in vitro induction of nonspecific killer cells by concanavalin A in mice.
    Mizushima Y, Iwata M, Sato M, Yano S.
    Tohoku J Exp Med; 1986 Jan 20; 148(1):79-85. PubMed ID: 3085284
    [Abstract] [Full Text] [Related]

  • 28. Augmentation of cytotoxicity of lymphokine activated killer cells on ovarian tumor cells by various biological response modifiers.
    Nio Y, Zighelboim J, Berek JS, Bonavida B.
    Anticancer Res; 1990 Jan 20; 10(2A):441-6. PubMed ID: 2346317
    [Abstract] [Full Text] [Related]

  • 29. OK-432 stimulates primary production and activity of murine natural killer cells.
    Pollack SB.
    Nat Immun Cell Growth Regul; 1987 Jan 20; 6(5):224-36. PubMed ID: 3444437
    [Abstract] [Full Text] [Related]

  • 30. Mechanism of tumoricidal activity of OK-432-specific L3T4+ Lyt2- T-cells.
    Ozaki S, Suginoshita T, Watanabe T, Obayashi H.
    Cancer Res; 1990 Aug 01; 50(15):4630-4. PubMed ID: 2369739
    [Abstract] [Full Text] [Related]

  • 31. [Induction of activated natural killer cells by the streptococcal preparation OK432 (I). Induction from spleen cells of normal or tumor-bearing mouse primed in vivo and subsequently challenged in vitro with OK432].
    Yamaue H, Tanimura H, Iwahashi M, Tani M, Tsunoda T, Tabuse K.
    Nihon Gan Chiryo Gakkai Shi; 1989 Jul 20; 24(7):1370-8. PubMed ID: 2809371
    [Abstract] [Full Text] [Related]

  • 32. [Effective mechanisms of BRM, with special reference to induction of autologous tumor cell-killing (ATK) activity by OK-432].
    Hoshino T, Uchida A.
    Gan To Kagaku Ryoho; 1986 Apr 20; 13(4 Pt 2):1277-84. PubMed ID: 3488024
    [Abstract] [Full Text] [Related]

  • 33. [Augmentation of cytotoxicity of regional lymph node lymphocytes of gastric cancer after intratumoral injection of OK-432].
    Kobayashi G.
    Nihon Geka Gakkai Zasshi; 1990 Jan 20; 91(1):68-76. PubMed ID: 2314383
    [Abstract] [Full Text] [Related]

  • 34. [Effect of OK-432 on activated lysozyme in monocytes and neutrophils --comparison of intravenous and intramuscular administrations].
    Fujii M, Okabe K, Tamai M, Toki H.
    Gan To Kagaku Ryoho; 1985 Feb 20; 12(2):383-4. PubMed ID: 3970558
    [No Abstract] [Full Text] [Related]

  • 35. [Production of a cytotoxic factor in mouse peritoneal fluid by OK-432, a streptococcal preparation].
    Yamamoto A, Nagamuta M, Usami H, Sugawara Y, Watanabe N, Niitsu Y, Urushizaki I.
    Gan To Kagaku Ryoho; 1986 May 20; 13(5):1905-10. PubMed ID: 3707150
    [Abstract] [Full Text] [Related]

  • 36. Killing of tumor cells with pleiotropic drug resistance by OK432-activated effector cells.
    Allavena P, Peccatori F, Maggioni D, Pirovano P, Mantovani A.
    Immunopharmacol Immunotoxicol; 1989 May 20; 11(2-3):257-68. PubMed ID: 2621319
    [Abstract] [Full Text] [Related]

  • 37. Induction of tumor necrosis factor by administration of OK-432 in cancer patients.
    Kokunai I, Shimano T, Sekimoto K, Takeda T, Kobayashi T, Yayoi E, Yamamoto A, Mori T.
    J Clin Lab Immunol; 1986 Dec 20; 21(4):169-71. PubMed ID: 3560194
    [Abstract] [Full Text] [Related]

  • 38. [Studies on the hepatoma cell injury by antibody-dependent cell-mediated cytotoxicity and its augmentation by pretreatment of macrophages with OK432].
    Mizoguchi Y, Tsutsui H, Yamamoto S, Morisawa S.
    Arerugi; 1984 Mar 20; 33(3):135-41. PubMed ID: 6466102
    [No Abstract] [Full Text] [Related]

  • 39. Synergistic actions of picibanil (OK-432) on recombinant interleukin-2 induction of tumor-infiltrating lymphocyte expansion, cytotoxicity, and phenotypic differentiation.
    Lafreniere R, Borkenhagen K, Bryant LD, Ng E, Hayton S.
    J Biol Response Mod; 1990 Feb 20; 9(1):53-60. PubMed ID: 2181072
    [Abstract] [Full Text] [Related]

  • 40. [Anticancer effects of OK-432 (2). Anticancer actions of M phi activated by OK-432].
    Saito M, Aonuma E, Noda T, Nakadate I, Nanjo M, Ebina T, Ishida N.
    Gan To Kagaku Ryoho; 1983 May 20; 10(5):1363-71. PubMed ID: 6870302
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.